Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial

被引：0

作者：

Anna E. C. Stoelinga

Maarten E. Tushuizen

Wilbert B. van den Hout

Mar D. M. Rodriguez Girondo

Elsemieke S. de Vries

Amar D. Levens

Dirk-Jan A. R. Moes

Tom J. G. Gevers

Suzanne van der Meer

Hans T. Brouwer

Hendrik J. M. de Jonge

Ynte S. de Boer

Ulrich H. W. Beuers

Adriaan J. van der Meer

Aad P. van den Berg

Maureen M. J. Guichelaar

Joost P. H. Drenth

Bart van Hoek

机构：

[1] Leiden University Medical Center,Department of Gastroenterology and Hepatology

[2] Leiden University Medical Center,Department of Biomedical Data Sciences

[3] Isala Hospital,Department of Gastroenterology and Hepatology

[4] Leiden University Medical Center,Department of Clinical Pharmacy and Toxicology

[5] Maastricht University Medical Center,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[6] European Reference Network RARE-LIVER,Department of Gastroenterology and Hepatology

[7] University Medical Center Utrecht,Department of Gastroenterology and Hepatology

[8] Reinier de Graaf Gasthuis,Department of Gastroenterology and Hepatology

[9] Jeroen Bosch Hospital,Department of Gastroenterology and Hepatology

[10] Amsterdam University Medical Centre,Department of Gastroenterology and Hepatology

[11] Location VU University Medical Center,Department of Gastroenterology and Hepatology

[12] Amsterdam University Medical Centre,Department of Gastroenterology and Hepatology

[13] Location Academic Medical Center,Department of Gastroenterology and Hepatology

[14] Erasmus University Medical Center,Department of Gastroenterology and Hepatology

[15] University Medical Center Groningen,Department of Gastroenterology and Hepatology

[16] Medisch Spectrum Twente,Department of Gastroenterology and Hepatology

[17] Radboud University Medical Center,Department of Gastroenterology and Hepatology

[18] Elisabeth Tweesteden Hospital,Department of Gastroenterology and Hepatology

[19] Rijnstate Hospital,undefined

[20] Haaglanden Medical Center,undefined

[21] Rode Kruis Hospital,undefined

来源：

Trials | / 25卷

关键词：

AIH; Autoimmune hepatitis; Autoimmune liver disease; Tacrolimus; Mycophenolate mofetil; Randomised controlled trials; Second-line treatment; Complete biochemical response;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial
Stoelinga, Anna E. C.
Tushuizen, Maarten E.
van den Hout, Wilbert B.
Girondo, Mar D. M. Rodriguez
de Vries, Elsemieke S.
Levens, Amar D.
Moes, Dirk-Jan A. R.
Gevers, Tom J. G.
van der Meer, Suzanne
Brouwer, Hans T.
de Jonge, Hendrik J. M.
de Boer, Ynte S.
Beuers, Ulrich H. W.
van der Meer, Adriaan J.
van den Berg, Aad P.
Guichelaar, Maureen M. J.
Drenth, Joost P. H.
van Hoek, Bart
TRIALS, 2024, 25 (01)
[2] Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
Liou, Jyh-Ming
Chen, Chieh-Chang
Chen, Mei-Jyh
Chen, Chien-Chuan
Chang, Chi-Yang
Fang, Yu-Jen
Lee, Ji-Yuh
Hsu, Shih-Jer
Luo, Jiing-Chyuan
Chang, Wen-Hsiung
Hsu, Yao-Chun
Tseng, Cheng-Hao
Tseng, Ping-Huei
Wang, Hsiu-Po
Yang, Ueng-Cheng
Shun, Chia-Tung
Lin, Jaw-Town
Lee, Yi-Chia
Wu, Ming-Shiang
LANCET, 2013, 381 (9862): : 205 - 213
[3] Prone versus lateral position in acute hypoxemic respiratory failure patients with HFNO therapy: study protocol for a multicentre randomised controlled open-label trial
Zhou, Xixin
Luo, Xiaoqing
Li, Qin
Chen, Guihua
Tong, Jin
Deng, Wang
TRIALS, 2023, 24 (01)
[4] Prone versus lateral position in acute hypoxemic respiratory failure patients with HFNO therapy: study protocol for a multicentre randomised controlled open-label trial
Xixin Zhou
Xiaoqing Luo
Qin Li
Guihua Chen
Jin Tong
Wang Deng
Trials, 24
[5] APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health - study protocol paper for a phase III multicentre, open-label randomised controlled trial
Slevin, Finbar
Hudson, Eleanor Mae
Boele, Florien W.
Powell, James R.
Noutch, Samantha
Borland, Myfanwy
Brown, Sarah
Bruce, Anna
Bulbeck, Helen
Burnet, Neil G.
Chang, Yen Ching
Colaco, Rovel
Currie, Stuart
Egleston, Daniel
Fersht, Naomi
Klein, Martin
Lilley, John
Lowe, Matthew
Miles, Elizabeth
Murray, Robert D.
O'Hara, Daniel J.
Norris, Matthew
Parbutt, Catherine
Smith, Alexandra
Smith, Charlotte
Whitfield, Gillian A.
Short, Susan
Murray, Louise
BMJ OPEN, 2025, 15 (02):
[6] Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol
Iwaki, Michihiro
Kobayashi, Takashi
Nogami, Asako
Ogawa, Yuji
Imajo, Kento
Sakai, Eiji
Nakada, Yoshinobu
Koyama, Satoshi
Kurihashi, Takeo
Oza, Noriko
Kohira, Toshikazu
Okada, Michiaki
Yamaguchi, Yuki
Iwane, Shinji
Kageyama, Fujito
Sasada, Yuzo
Matsushita, Masahiro
Tadauchi, Akimitsu
Murohisa, Gou
Nagasawa, Masamichi
Sato, Shuichi
Maeda, Kazuhisa
Furuta, Koichiro
Shigefuku, Ryuta
Seko, Yuya
Tobita, Hiroshi
Kawata, Kazuhito
Kawanaka, Miwa
Sugihara, Takaaki
Tamaki, Nobuharu
Iwasa, Motoh
Kawaguchi, Takumi
Itoh, Yoshito
Kawaguchi, Atsushi
Takahashi, Hirokazu
Nakajima, Atsushi
Yoneda, Masato
BMJ OPEN, 2024, 14 (11):
[7] Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
Hutson, Thomas E.
Lesovoy, Vladimir
Al-Shukri, Salman
Stus, Viktor P.
Lipatov, Oleg N.
Bair, Angel H.
Rosbrook, Brad
Chen, Connie
Kim, Sinil
Vogelzang, Nicholas J.
LANCET ONCOLOGY, 2013, 14 (13): : 1287 - 1294
[8] Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial
Romée J. A. L. M. Snijders
Anna E. C. Stoelinga
Tom J. G. Gevers
Simon Pape
Maaike Biewenga
Robert C. Verdonk
Hendrik J. M. de Jonge
Jan Maarten Vrolijk
Sjoerd F. Bakker
Thomas Vanwolleghem
Ynto S. de Boer
Martine A. M. C. Baven Pronk
Ulrich H. W. Beuers
Adriaan J. van der Meer
Nicole M. F. van Gerven
Marijn G. M. Sijtsma
Bart J. Verwer
Ingrid A. M. Gisbertz
Maartje Bartelink
Floris F. van den Brand
Kerem Sebib Korkmaz
Aad P. van den Berg
Maureen M. J. Guichelaar
Khalida Soufidi
Amar D. Levens
Bart van Hoek
Joost P. H. Drenth
Trials, 23
[9] Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial
Snijders, Romee J. A. L. M.
Stoelinga, Anna E. C.
Gevers, Tom J. G.
Pape, Simon
Biewenga, Maaike
Verdonk, Robert C.
de Jonge, Hendrik J. M.
Vrolijk, Jan Maarten
Bakker, Sjoerd F.
Vanwolleghem, Thomas
de Boer, Ynto S.
Pronk, Martine A. M. C. Baven
Beuers, Ulrich H. W.
van Der Meer, Adriaan J.
van Gerven, Nicole M. F.
Sijtsma, Marijn G. M.
Verwer, Bart J.
Gisbertz, Ingrid A. M.
Bartelink, Maartje
van den Brand, Floris F.
Korkmaz, Kerem Sebib
van den Berg, Aad P.
Guichelaar, Maureen M. J.
Soufidi, Khalida
Levens, Amar D.
van Hoek, Bart
Drenth, Joost P. H.
TRIALS, 2022, 23 (01)
[10] An open-label phase II study of sorafenib and dacarbazine as first-line therapy in patients with advanced melanoma
Eisen, T.
Marais, R.
Affolter, A.
Lorigan, P.
Ottensmeier, C.
Robert, C.
Corrie, P.
Chevreau, C.
Erlandsson, F.
Gore, M.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)

← 1 2 3 4 5 →